We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

IVIG (Gamunex-C) Treatment Study for POTS Subjects (iSTAND)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03919773
Recruitment Status : Enrolling by invitation
First Posted : April 18, 2019
Last Update Posted : January 24, 2022
Grifols Biologicals, LLC
Dysautonomia International
Information provided by (Responsible Party):
Steven Vernino, University of Texas Southwestern Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : September 2023
Estimated Study Completion Date : December 2023